FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of ...

"Given the fact that there are states, counties, cities, school districts, pension funds, and other plaintiffs from all over ...

In a report released today, Charles Rhyee from TD Cowen maintained a Buy rating on CVS Health (CVS – Research Report), with a price target of ...

Thank you for getting the latest news across America from the Your Morning newsletter. For more fact-based, unbiased news ...

Independent drugstores are closing at an alarming rate — about one a day in 2023 — squeezed by the huge companies that ...